Messenger RNA levels of podocyte-associated proteins in subjects with different degrees of glucose tolerance with or without nephropathy

BMC Nephrology

Volumn 14, Issue 1, 2013, Pages

  Do Nascimento, Jonathan Fraportti ^a   Canani, Luis H ^b   Gerchman, Fernando ^b   Rodrigues, Patricia G ^a   Joelsons, Gabriel ^a   Dos Santos, Mariane ^a   Pereira, Sane ^a   Veronese, Francisco V ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Diabetic nephropathy; Nephrin; Podocyte; Prediabetes; TRPC6

Indexed keywords

ALPHA ACTININ 4; COMPLEMENTARY DNA; CREATININE; MESSENGER RNA; NEPHRIN; PODOCALYXIN; PODOCIN; SYNAPTOPODIN; TRANSFORMING GROWTH FACTOR BETA1;

ALBUMINURIA; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; GENDER; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLYCEMIC CONTROL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; KIDNEY DISEASE; KIDNEY FUNCTION; MACROALBUMINURIA; ORAL GLUCOSE TOLERANCE TEST; PODOCYTE; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SYSTOLIC BLOOD PRESSURE; URINALYSIS; URINARY EXCRETION; URINE SEDIMENT;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS; DIABETIC NEPHROPATHIES; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; MALE; MIDDLE AGED; PODOCYTES; PROTEINURIA; PROTEOME; RNA, MESSENGER;

EID: 84885015472     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-14-214     Document Type: Article

References (42)

1. report of the Brazilian dialysis census. Sesso RC, Lopes AA, Thomé FS, Lugon JR, Santos DR, J Bras Nefrol 2011 33 442 447 10.1590/S0101- 28002011000400009 221898082010
2. Podocytopathy in diabetes: a metabolic and endocrine disorder. Diez-Sampedro A, Lenz O, Fornoni A, Am J Kidney Dis 2011 58 637 646 10.1053/j.ajkd.2011.03.035 21719174
3. From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy. Wolf G, Chen S, Ziyadeh FN, Diabetes 2005 54 1626 1634 10.2337/diabetes.54.6.1626 15919782 (Pubitemid 40770751)
4. Podocyte detachment and reduced glomerular capillary endothelial fenestration in human type 1 diabetic nephropathy. Toyoda M, Najafian B, Kim Y, Caramori ML, Mauer M, Diabetes 2007 56 2155 2160 10.2337/db07-0019 17536064 (Pubitemid 47195834)
5. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Susztak K, Raff AC, Schiffer M, Bottinger EP, Diabetes 2006 55 225 233 10.2337/diabetes.55.01.06. db05-0894 16380497 (Pubitemid 43343319)
6. RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy. Wendt TM, Tanji N, Guo J, Kislinger TR, Qu W, Lu Y, et al. Am J Pathol 2003 162 1123 1137 10.1016/S0002-9440(10)63909-0 12651605 (Pubitemid 36350658)
7. From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines. Schrijvers BF, De Vriese AS, Flyvbjerg A, Endocr Rev 2004 25 971 1010 10.1210/er.2003-0018 15583025 (Pubitemid 39657775)
8. Apical cell membranes are shed into urine from injured podocytes: a novel phenomenon of podocyte injury. Hara M, Yanagihara T, Kihara I, Higashi K, Fujimoto K, Kajita T, J Am Soc Nephrol 2005 16 408 416 10.1681/ASN.2004070564 15625073 (Pubitemid 41725136)
9. Podocyte damage resulting in podocyturia: a potential diagnostic marker to assess glomerular disease activity. Petermann A, Floege J, Nephron Clin Pract 2007 106 61 66 10.1159/000101799 (Pubitemid 46933393)
10. Glomerular epithelial cells in the urine: what has to be done to make them worthwhile? Skoberne A, Konieczny A, Schiffer M, Am J Physiol Renal Physiol 2009 296 230 241
11. Advances in the biology and genetics of the podocytopathies. Barisoni L, Schnaper W, Koop JB, Arch Pathol Lab Med 2009 133 201 216 19195964
12. Induction of TRPC6 channel in acquired forms of proteinuric kidney disease. Möller CC, Wei C, Altintas MM, Li J, Greka A, Ohse T, et al. J Am Soc Nephrol 2007 18 29 36 10.1681/ASN.2006091010 17167110 (Pubitemid 46053419)
13. Diabetic nephropathy and transforming growth factor-beta: transforming our view of glomerulosclerosis and fibrosis build-up. Chen S, Jim B, Ziyadeh FN, Semin Nephrol 2003 23 532 543 10.1053/S0270-9295(03)00132-3 14631561 (Pubitemid 38030087)
14. Urinary excretion of podocytes in patients with diabetic nephropathy. Nakamura T, Ushiyama C, Suzuki S, Hara M, Shimada N, Ebihara I, et al. Nephrol Dial Transplant 2000 15 1379 1383 10.1093/ndt/15.9.1379 10978394
15. Messenger RNA expression of podocyte-associated molecules in the urinary sediment of patients with diabetic nephropathy. Wang G, Lai FM, Lai KB, Chow KM, Li KT, Szeto CC, Nephron Clin Pract 2007 106 169 179 10.1159/000104428 (Pubitemid 47172277)
16. Nephrinuria associates with multiple renal traits in type 2 diabetes. Ng DP, Tai BC, Tan E, Leong H, Nurbaya S, Lim XL, et al. Nephrol Dial Transplant 2011 26 2508 2514 10.1093/ndt/gfq738 21196468
17. Podocyte as a potential target of inflammation: role of hydrochloride pioglitazone in type 2 diabetics. Xing Y, Ye S, Hu Y, Chen Y, Endocrinol Pract 2012 18 493 498 10.4158/EP11378.OR
18. Urinary messenger RNA expression of podocyte-associated molecules in patients with diabetic nephropathy treated by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker. Wang G, Lai FM, Lai KB, Chow KM, Kwan BC, Li PK, et al. Eur J Endocrinol 2008 158 317 322 10.1530/EJE-07-0708 18299464 (Pubitemid 351404995)
19. Diagnosis and classification of diabetes mellitus. American Diabetes Association, Diabetes Care 2010 33 62 69
20. A new equation to estimate glomerular filtration rate. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI 3rd, et al. Ann Intern Med 2009 150 604 612 10.7326/0003-4819-150-9-200905050-00006 19414839
21. WINPEPI (PEPI-for-Windows): computer programs for epidemiologists. Abramson JH, Epidemiol Perspect Innov 2004 1 6 10.1186/1742-5573-1-6 15606913 (Pubitemid 40404933)
22. The podocyte: a potential therapeutic target in diabetic nephropathy? Marshall SM, Curr Pharma Des 2007 13 2713 2720 10.2174/138161207781662957 (Pubitemid 47423663)
23. Nephrin expression is reduced in human diabetic nephropathy: evidence for a distinct role for glycated albumin and angiotensin II. Doublier S, Salvidio G, Lupia E, Ruotsalainen V, Verzola D, Deferrari G, et al. Diabetes 2003 52 1023 1030 10.2337/diabetes.52.4.1023 12663475 (Pubitemid 36384273)
24. Apoptosis in the kidneys of patients with type II diabetic nephropathy. Verzola D, Gandolfo MT, Ferrario F, Rastaldi MP, Villaggio B, Gianiorio F, et al. Kidney Int 2007 72 1262 1272 10.1038/sj.ki.5002531 17851466 (Pubitemid 350059668)
25. Glomerular cell number in normal subjects and in type 1 diabetic patients. Steffes MW, Schmidt D, McCrery R, Basgen JM, Kidney Int 2001 59 2104 2113 11380812 (Pubitemid 32467602)
26. Messenger RNA expression of glomerular podocyte markers in the urinary sediment of acquired proteinuric diseases. Szeto CC, Lai KB, Chow KM, Szeto CY, Yip TW, Woo KS, et al. Clin Chim Acta 2005 361 182 190 10.1016/j.cccn.2005.05. 016 15996647 (Pubitemid 41382622)
27. Urinary excretion of viable podocytes in health and renal disease. Vogelmann SU, Nelson WJ, Myers BD, Lemley KV, Am J Physiol Renal Physiol 2003 285 40 48
28. Urinary podocyte-associated mRNA profile in various stages of diabetic nephropathy. Zheng M, Lv LL, Ni J, Ni HF, Li Q, Ma KL, et al. PLoS One 2011 6 20431 10.1371/journal.pone.0020431
29. Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes. Dalla Vestra M, Masiero A, Roiter AM, Saller A, Crepaldi G, Fioretto P, Diabetes 2003 52 1031 1035 10.2337/diabetes.52.4.1031 12663476 (Pubitemid 36384274)
30. Podocyte number predicts long-term urinary albumin excretion in Pima Indians with Type II diabetes and microalbuminuria. Meyer TW, Bennett PH, Nelson RG, Diabetologia 1999 42 1341 1344 10.1007/s001250051447 10550418 (Pubitemid 29500971)
31. Podocyte number in normotensive type 1 diabetic patients with albuminuria. White KE, Bilous RW, Marshall SM, El Nahas M, Remuzzi, Piras GP, et al. Diabetes 2002 51 3083 3089 10.2337/diabetes.51.10.3083 12351451
32. Selective impairment of gene expression and assembly of nephrin in human diabetic nephropathy. Benigni A, Gagliardini E, Tomasoni S, et al. Kidney Int 2004 65 2193 2200 10.1111/j.1523-1755.2004.00636.x 15149332 (Pubitemid 38670005)
33. Dysregulated nephrin in diabetic nephropathy of type 2 diabetes: a cross sectional study. Jim B, Ghanta M, Qipo A, Fan Y, Chuang PY, Cohen HW, et al. PLoS One 2012 7 36041 10.1371/journal.pone.0036041 22615747
34. Abundance of TRPC6 protein in glomerular mesangial cells is decreased by ROS and PKC in diabetes. Graham S, Gorin Y, Abboud HE, Ding M, Lee DY, Shi H, et al. Am J Physiol Cell Physiol 2011 301 304 315 10.1152/ajpcell.00014.2011
35. Nephrinuria in diabetic nephropathy of type 1 diabetes. Patäri A, Forsblom C, Havana M, Taipale H, Groop PH, et al. Diabetes 2003 52 2969 2974 10.2337/diabetes.52.12.2969 14633858 (Pubitemid 37466867)
36. Glomerular permselectivety at the onset of nephropathy in type 2 diabetes mellitus. Lemley KV, Blouch K, Abdullah I, Boothroyd DB, Bennett PH, Myers BD, et al. J Am Soc Nephrol 2000 11 2095 2105 11053486
37. Expression of alpha-actinin-4 in human diabetic nephropathy. Kimura M, Toyoda M, Kato M, Kobayashi K, Abe M, Kobayashi T, Intern Med 2008 47 1099 1106 10.2169/internalmedicine.47.0352 18552466
38. High glucose and advanced glycosylated end products affect expression of alpha-actinin-4 in glomerular epithelial cells. Ha TS, Nephrology 2006 17 57 68
39. TRPC6 channels and their binding partners in podocytes: role in glomerular filtration and pathophysiology. Dryer SE, Reiser J, Am J Physiol Renal Physiol 2010 299 689 701 10.1152/ajprenal.00298.2010
40. TGFbeta concentration specifies differential signaling profiles of growth arrest/differentiation and apoptosis in podocytes. WuDT BM, Ju W, Mundel P, Böttinger EP, J Am Soc Nephrol 2005 16 3211 3221 10.1681/ASN.2004121055 16207831 (Pubitemid 46179327)
41. Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli. Wahab NA, Schaefer L, Weston BS, Yiannikouris O, Wright A, Babelova A, et al. Diabetologia 2005 48 2650 2660 10.1007/s00125-005-0006-5 16270194 (Pubitemid 41738234)
42. Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in the diabetic nephropathy: effects of angiotensin converting enzyme I inhibition. Langham RG, Kelly DJ, Cox AJ, Thomson NM, Holthöfer H, Pinel N, et al. Diabetologia 2002 45 1572 1576 10.1007/s00125-002-0946-y 12436341 (Pubitemid 35352051)